Clinical Trials

Showing trials with last updates posted in 2024.

NCT02628405 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
30 participants

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-01
Start Date:
2016-05-20
Completion:
2021-09-24
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Recurrent Transformed Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Refractory Transformed Non-Hodgkin Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page